52. Kim H. J., Kim C. Y., Park E. K., Hur Y. H., Koh Y. S., Kim H. J., Cho C.
K. (2014), Volumetric analysis and indocyanine green retention rate at 15min as predictors of posthepatectomy liver failure, HPB, 17(2), 159- 167.
53. Kim J. M., Kwon C. H., Joh J. W., Park J. B., Lee J. H., Kim G. S., Kim S. J., Paik S. W. (2014), Can the model for end-stage liver disease score replace the indocyanine green clearance test in the selection of right hemihepatectomy in Child-Pugh class A?, Ann Surg Treat Res, 86(3), 122-129.
54. Knodell R. G., Ishak K. G., Black W. C., Chen T. S., Craig R., Kaplowitz N., Kiernan T. W., Wollman J. (1981), Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis, Hepatology, 1(5), 431-5.
55. Kobayashi Y., Kiya Y., Sugawara T., Nishioka Y., Hashimoto M., Shindoh
J. (2019), Expanded Makuuchi's criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection, HPB (Oxford), 21(8), 990-997.
56. Kumar N., Duncan T., O'Reilly D., Kaposztas Z., Parry C., Rees J., Junnarkar S. (2019), Partial ALPPS with a longer wait between procedures is safe and yields adequate future liver remnant hypertrophy, Ann Hepatobiliary Pancreat Surg, 23(1), 13-19.
57. Lam C. M., Fan S. T., Lo C. M., Wong J. (1999), Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test, Br J Surg, 86(8), 1012-1017.
58. Lao X. M., Zhang Y. Q., Guan Y. X., Guo R. P., Lin X. J., Yuan Y. F., Li
Có thể bạn quan tâm!
- Liên Quan Giữa Đặc Điểm Trong Mổ Và Suy Gan Sau Phẫu Thuật Cắt Gan
- So Sánh Hiệu Quả Của Các Mô Hình Tiên Lượng Suy Gan Sau Phẫu Thuật Cắt Gan Lớn
- Giá trị tiên lượng chức năng gan của độ thanh lọc indocyanine green trong phẫu thuật cắt gan - 15
- Giá trị tiên lượng chức năng gan của độ thanh lọc indocyanine green trong phẫu thuật cắt gan - 17
Xem toàn bộ 138 trang tài liệu này.
J. Q., Li G. H. (2004), Evaluation of liver reserve function by ICGR15
detection before hepatectomy for hepatocellular carcinoma, Ai Zheng, 23(10), 1213-1217.
59. Lao X. M., Zhang Y. Q., Lin X. J., Guo R. P., Chen M. S., Yuan Y. F., Li
J. Q., Li G. H. (2005), Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure, Ai Zheng, 24(3), 337-340.
60. Lee C. F., Yu M. C., Kuo L. M., Chan K. M., Jan Y. Y., Chen M. F., Lee
W. C. (2007), Using indocyanine green test to avoid post-hepatectomy liver dysfunction, Chang Gung Med J, 30(4), 333-338.
61. Lee S.-G., Hwang S. (2005), How I do it: assessment of hepatic functional reserve for indication of hepatic resection12(1), 38-43.
62. Li J., Lei B., Nie X., Lin L., Tahir S. A., Shi W., Jin J., He S. (2015), A comprehensive method for predicting fatal liver failure of patients with liver cancer resection, Medicine (Baltimore), 94(17), 784.
63. Lisotti A., Azzaroli F., Buonfiglioli F., Montagnani M., Cecinato P., Turco L., Calvanese C., Simoni P., Guardigli M., Arena R., Cucchetti A., Colecchia A., Festi D., Golfieri R., Mazzella G. (2014), Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis, Hepatology, 59(2), 643-650.
64. Lisotti A., Azzaroli F., Cucchetti A., Buonfiglioli F., Cecinato P., Calvanese C., Simoni P., Arena R., Montagnani M., Golfieri R., Colecchia A., Festi D., Mazzella G. (2016), Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension, Liver Int, 36(9), 1313-1321.
65. Loffroy R., Favelier S., Chevallier O., Estivalet L., Genson P. Y., Pottecher P., Gehin S., Krause D., Cercueil J. P. (2015), Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes, Quant Imaging Med Surg, 5(5), 730-739.
66. Lu H. S., Hsin I. F., Chen P. H., Yang T. C., Chang C. Y., Huang Y. H., Hou M. C. (2020), The indocyanine green retention test as a noninvasive marker for esophageal varices in patients with hepatocellular carcinoma, J Chin Med Assoc, 83(8), 737-742.
67. Martin E. F., O'Brien C. (2015), Update on MELD and organ allocation5(4), 105-107.
68. Miyagawa S., Makuuchi M., Kawasaki S., Kakazu T. (1995), Criteria for safe hepatic resection, Am J Surg, 169(6), 589-594.
69. Moller S., la Cour Sibbesen E., Madsen J. L., Bendtsen F. (2018), Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease, J Gastroenterol Hepatol, 34(6), 1093-1099.
70. Mullen J. T., Ribero D., Reddy S. K., Donadon M., Zorzi D., Gautam S., Abdalla E. K., Curley S. A., Capussotti L., Clary B. M., Vauthey J.-N. (2007), Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy, Journal of the American College of Surgeons, 204(5), 854-862.
71. Nakamura N., Hatano E., Iguchi K., Seo S., Taura K., Uemoto S. (2016), Posthepatectomy Liver Failure Affects Long-Term Function After Resection for Hepatocellular Carcinoma, World J Surg, 40(4), 929- 936.
72. Navarro J. G., Yang S. J., Kang I., Choi G. H., Han D. H., Kim K. S., Choi
J. S. (2020), What are the most important predictive factors for
clinically relevant posthepatectomy liver failure after right hepatectomy for hepatocellular carcinoma?, Ann Surg Treat Res, 98(2), 62-71.
73. Omata M., Cheng A. L., Kokudo N., Kudo M., Lee J. M., Jia J., Tateishi R., Han K. H., Chawla Y. K., Shiina S., Jafri W., Payawal D. A., Ohki T., Ogasawara S., Chen P. J., Lesmana C. R. A., Lesmana L. A., Gani
R. A., Obi S., Dokmeci A. K., Sarin S. K. (2017), Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update, Hepatol Int, 11(4), 317-370.
74. Peng P. D., Hyder O., Bloomston M., Marques H., Corona-Villalobos C., Dixon E., Pulitano C., Hirose K., Schulick R. D., Barroso E., Aldrighetti L., Choti M., Shen F., Kamel I., Geschwind J. F., Pawlik T.
M. (2012), Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies, HPB (Oxford), 14(8), 523-531.
75. Pind M. L., Bendtsen F., Kallemose T., Moller S. (2016), Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis, Eur J Gastroenterol Hepatol, 28(8), 948-954.
76. Pugh R. N. H., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams
R. (1973), Transection of the oesophagus for bleeding oesophageal varices60(8), 646-649.
77. Rahbari N. N., Garden O. J., Padbury R., Brooke-Smith M., Crawford M., Adam R., Koch M., Makuuchi M., Dematteo R. P., Christophi C., Banting S., Usatoff V., Nagino M., Maddern G., Hugh T. J., Vauthey J.-N., Greig P., Rees M., Yokoyama Y., Fan S. T., Nimura Y., Figueras J., Capussotti L., Büchler M. W., Weitz J. (2011), Posthepatectomy
liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS), Surgery, 149(5), 713-724.
78. Ray S., Mehta N. N., Golhar A., Nundy S. (2018), Post hepatectomy liver failure - A comprehensive review of current concepts and controversies, Ann Med Surg (Lond), 34, 4-10.
79. Reddy S. K., Barbas A. S., Turley R. S., Steel J. L., Tsung A., Marsh J. W., Geller D. A., Clary B. M. (2011), A standard definition of major hepatectomy: resection of four or more liver segments, HPB (Oxford), 13(7), 494-502.
80. Sagawa E., Okubo H., Sorin Y., Nakadera E., Fukada H., Igusa Y., Kokubu S., Miyazaki A., Watanobe I., Sugo H., Kojima K., Watanabe S. (2017), Use of finger-piece method for indocyanine green clearance test, Hepatol Res, 47(12), 1235-1240.
81. Sheng Q. S., Lang R., He Q., Yang Y. J., Zhao D. F., Chen D. Z. (2009), Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis, Hepatobiliary Pancreat Dis Int, 8(1), 46-49.
82. Shinkawa H., Takemura S., Tanaka S., Kubo S. (2017), Portal Vein Embolization: History and Current Indications, Visc Med, 33(6), 414- 417.
83. Skrzypczyk C., Truant S., Duhamel A., Langlois C., Boleslawski E., Koriche D., Hebbar M., Fourrier F., Mathurin P., Pruvot F. R. (2014), Relevance of the ISGLS definition of posthepatectomy liver failure in early prediction of poor outcome after liver resection: study on 680 hepatectomies, Ann Surg, 260(5), 865-870.
84. Stockmann M., Malinowski M., Lock J. F., Seehofer D., Neuhaus P. (2009), Factors influencing the indocyanine green (ICG) test:
additional impact of acute cholestasis, Hepatogastroenterology, 56(91- 92), 734-738.
85. Strasberg S. M., Belghiti J., Clavien P. A., Gadzijev E., Garden J. O., Lau
W. Y., Makuuchi M., Strong R. W. (2000), The Brisbane 2000 Terminology of Liver Anatomy and Resections, HPB, 2(3), 333-339.
86. Sultana A., Brooke-Smith M., Ullah S., Figueras J., Rees M., Vauthey J. N., Conrad C., Hugh T. J., Garden O. J., Fan S. T., Crawford M., Makuuchi M., Yokoyama Y., Buchler M., Padbury R. (2018), Prospective evaluation of the International Study Group for Liver Surgery definition of post hepatectomy liver failure after liver resection: an international multicentre study, HPB (Oxford), 20(5), 462-469.
87. Szijarto A., Hargitai B., Fischer S., Darvas K., Kupcsulik P. (2009), Two- staged procedure of portal ligation and hepatectomy monitored by ICG clearance, J Invest Surg, 22(1), 63-68.
88. Tang Y. H., Luo Y., Wen T. F., Lu Q., Jiang L., Zhu W. J. (2014), Portal hemodynamics before and after liver resection and its correlation with post-hepatectomy liver failure in patients with Child-Pugh class A: analysis of 151 consecutive cases, Hepatogastroenterology, 61(129), 42-7.
89. Terasawa M., Allard M. A., Golse N., Sa Cunha A., Cherqui D., Adam R., Saiura A., Vibert E. (2020), Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis, Surgery, 167(2), 425-431.
90. Thasler W. E., Bein T., Jauch K. W. (2002), Perioperative effects of hepatic resection surgery on hemodynamics, pulmonary fluid balance, and indocyanine green clearance, Langenbecks Arch Surg, 387(7-8), 271- 275.
91. Tomimaru Y., Eguchi H., Gotoh K., Kawamoto K., Wada H., Asaoka T., Noda T., Yamada D., Ogawa H., Umeshita K., Nagano H., Doki Y., Mori M. (2016), Platelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocellular carcinoma than indocyanine green clearance test, J Surg Oncol, 113(5), 565-569.
92. Tralhao J. G., Hoti E., Oliveiros B., Botelho M. F., Sousa F. C. (2012), Study of perioperative liver function by dynamic monitoring of ICG- clearance, Hepatogastroenterology, 59(116), 1179-1183.
93. Truty M. J., Vauthey J.-N. (2010), Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique, Annals of surgical oncology, 17(5), 1219-1225.
94. Ulmer T. F., de Jong C., Andert A., Bruners P., Heidenhain C. M., Schoening W., Schmeding M., Neumann U. P. (2017), ALPPS Procedure in Insufficient Hypertrophy After Portal Vein Embolization (PVE), World J Surg, 41(1), 250-257.
95. Urata K., Kawasaki S., Matsunami H., Hashikura Y., Ikegami T., Ishizone S., Momose Y., Komiyama A., Makuuchi M. (1995), Calculation of child and adult standard liver volume for liver transplantation, Hepatology, 21(5), 1317-1321.
96. van Lienden K. P., van den Esschert J. W., de Graaf W., Bipat S., Lameris
J. S., van Gulik T. M., van Delden O. M. (2013), Portal vein
embolization before liver resection: a systematic review, Cardiovasc Intervent Radiol, 36(1), 25-34.
97. Vauthey J. N., Abdalla E. K., Doherty D. A., Gertsch P., Fenstermacher M. J., Loyer E. M., Lerut J., Materne R., Wang X., Encarnacion A., Herron D., Mathey C., Ferrari G., Charnsangavej C., Do K. A., Denys A. (2002), Body surface area and body weight predict total liver volume in Western adults, Liver Transpl, 8(3), 233-240.
98. Vennarecci G., Ferraro D., Tudisco A., Levi Sandri G. B., Guglielmo N., Berardi G., Sperduti I., Ettorre G. M. (2019), The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience, Updates in surgery, 71(1), 67-75.
99. Wakiya T., Kudo D., Toyoki Y., Ishido K., Kimura N., Narumi S., Kijima H., Hakamada K. (2014), Evaluation of the Usefulness of the Indocyanine Green Clearance Test for Chemotherapy-Associated Liver Injury in Patients with Colorectal Cancer Liver Metastasis, Annals of Surgical Oncology, 21(1), 167-172.
100. Wang Y. Y., Zhao X. H., Ma L., Ye J. Z., Wu F. X., Tang J., You X. M., Xiang B. D., Li L. Q. (2018), Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma, J Surg Oncol, 118(3), 440-445.
101. Yadav K., Shrikhande S., Goel M. (2014), Post hepatectomy liver failure: concept of management, J Gastrointest Cancer, 45(4), 405-413.
102. Yamamoto G., Taura K., Ikai I., Fujikawa T., Nishitai R., Kaihara S., Zaima M., Terajima H., Yoshimura T., Koyama Y., Tanabe K., Nishio T., Okuda Y., Ikeno Y., Yoshino K., Fukuyama K., Seo S., Hatano E., Uemoto S. (2020), ALPlat criterion for the resection of hepatocellular